These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12063044)

  • 1. The subclassification and long-term prognosis of preproliferative diabetic retinopathy.
    Sato Y; Lee Z
    Jpn J Ophthalmol; 2002; 46(3):323-9. PubMed ID: 12063044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The sub-classification and long-term prognosis of preproliferative diabetic retinopathy].
    Sato Y; Lee Z
    Nippon Ganka Gakkai Zasshi; 2001 Jun; 105(6):394-8. PubMed ID: 11449689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclassification of preproliferative diabetic retinopathy and glycemic control: relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy.
    Sato Y; Lee Z; Hayashi Y
    Jpn J Ophthalmol; 2001; 45(5):523-7. PubMed ID: 11583677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preproliferative diabetic retinopathy sub-classification and glycemic control--relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy].
    Sato Y; Lee Z; Hayashi Y
    Nippon Ganka Gakkai Zasshi; 2001 May; 105(5):322-5. PubMed ID: 11406948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclassification of preproliferative diabetic retinopathy.
    Sato Y; Kamata A; Matsui M
    Jpn J Ophthalmol; 1993; 37(4):490-8. PubMed ID: 8145395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photopic electroretinogram implicit time in diabetic retinopathy.
    Satoh S; Iijima H; Imai M; Abe K; Shibuya T
    Jpn J Ophthalmol; 1994; 38(2):178-84. PubMed ID: 7967210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferative retinopathy--pathogenesis and classification from the aspect if indications for laser photocoagulation, and its incidence in materials of the Eye Clinic in Wroclaw].
    Nizankowska MH; Lukasik-Czerek A; Oficjalska-Młyńczak J
    Klin Oczna; 1995; 97(9-10):276-8. PubMed ID: 8833948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.
    Lee CS; Lee AY; Baughman D; Sim D; Akelere T; Brand C; Crabb DP; Denniston AK; Downey L; Fitt A; Khan R; Mahmood S; Mandal K; Mckibbin M; Menon G; Lobo A; Kumar BV; Natha S; Varma A; Wilkinson E; Mitry D; Bailey C; Chakravarthy U; Tufail A; Egan C;
    Am J Ophthalmol; 2017 Aug; 180():64-71. PubMed ID: 28572062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy.
    ; Sato Y; Kojimahara N; Kitano S; Kato S; Ando N; Yamaguchi N; Hori S
    Jpn J Ophthalmol; 2012 Jan; 56(1):52-9. PubMed ID: 22009219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Observation on clinical effects of panretinal coagulation for diabetic retinopathy].
    Qian Z; Zhu L; Zhao C
    Yan Ke Xue Bao; 2002 Jun; 18(2):99-101. PubMed ID: 15510646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
    Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foveal avascular zone in diabetes mellitus.
    Mansour AM; Schachat A; Bodiford G; Haymond R
    Retina; 1993; 13(2):125-8. PubMed ID: 8337493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in choroidal thickness in patients with diabetic retinopathy.
    Ohara Z; Tabuchi H; Nakakura S; Yoshizumi Y; Sumino H; Maeda Y; Kiuchi Y
    Int Ophthalmol; 2018 Feb; 38(1):279-286. PubMed ID: 28194551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan.
    Liu WJ; Lee LT; Yen MF; Tung TH; Williams R; Duffy SW; Chen TH
    Diabet Med; 2003 Sep; 20(9):727-33. PubMed ID: 12925052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic Retinopathy -Incidence And Risk Factors In A Community Setting- A Longitudinal Study.
    Shani M; Eviatar T; Komaneshter D; Vinker S
    Scand J Prim Health Care; 2018 Sep; 36(3):237-241. PubMed ID: 29947279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of diabetic retinopathy progression in women with diabetes mellitus during pregnancy].
    Pomytkina NV; Sorokin EL
    Vestn Oftalmol; 2023; 139(3):30-40. PubMed ID: 37379107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The sub-classification of pre-proliferative diabetic retinopathy].
    Sato Y; Kamata A; Matsui M
    Nippon Ganka Gakkai Zasshi; 1993 Feb; 97(2):247-52. PubMed ID: 8475838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.